IP Library › Granted Patent US 11,517,639
Granted Patent B2
US 11,517,639 · App. 16/526,899 · Granted Dec 6, 2022

Generating cold plasma away from skin, and associated systems and methods

Inventors: Ozgur Emek Yildirim (Bellevue, WA); Thi Hong Lien Planard-Luong (Chevilly Larue, FR); Matthieu Jacob (Chevilly Larue, FR); Geoffrey Deane (Bellevue, WA)
Assignee: L'Oreal
A61L2/14A61N1/44A61B18/042A61L9/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,517,639
App. No.
16/526,899
Granted
Dec 6, 2022
Kind
B2
Abstract

A cold plasma system and method for treating a region of a biological surface is presented. In one embodiment, the system includes: a housing; an air conduit within the housing; a first electrode configured proximately along the air conduit; a second electrode configured proximately along the air conduit and opposite from the first electrode; and a source of alternating current (AC) electrically connected with the first electrode. The source of alternating current is configured to generate cold plasma in the air conduit.

Claims (22)

1. A cold plasma system for treating a region of a biological surface, the system comprising:

a housing;

an air conduit within the housing;

a first electrode configured proximately along the air conduit;

a second electrode configured proximately along the air conduit and opposite from the first electrode;

a source of alternating current (AC) electrically connected with the first electrode, wherein the source of alternating current is configured to generate a cold plasma in the air conduit;

a reservoir configured within the housing, wherein the reservoir is in a fluid communication with the air conduit, and wherein the reservoir is configured for holding the cold plasma; and

a cartridge containing a plasma precursor, wherein the cartridge is inserted into the housing, wherein the cartridge is in a fluid communication with the air conduit,

wherein the air conduit is a first air conduit connecting the reservoir and the cartridge, the system further comprising:

a first air mover configured to transport the cold plasma from the cartridge through the first air conduit toward the reservoir;

a second air conduit connecting the reservoir and the cartridge;

a second air mover configured to transport the cold plasma back from the reservoir toward the cartridge; and

a controller configured to control a speed of rotation of the first air mover and a speed of rotation of the second air mover based on a difference between a present concentration and a target concentration of the cold plasma in the reservoir, wherein the target concentration is selected at least in part based on a half-life of the cold plasma.

2. The system of claim 1 , further comprising a third air mover configured to direct the cold plasma out of the cold plasma system, and toward the biological surface.

3. The system of claim 1 , wherein the plasma precursor includes precursor components that generate reactive oxygen species or reactive nitrogen species (RONS) in the cold plasma that include at least one of hydroxyl (OH), atomic oxygen (O), singlet delta oxygen (02(1Δ)), superoxide (02-), hydrogen peroxide (H2O2), and nitric oxide (NO).

4. The system of claim 1 , further comprising means for controlling a flow of cold plasma, wherein the means are selected from a group consisting of:

a compressible skirt configured to contain the cold plasma proximate to the biological surface;

a face mask configured to contain the cold plasma proximate to the biological surface, wherein a mask intake is in fluid communication with the air conduit; and

a plurality of electromagnetic field generator units configured to steer or bend a discharge direction of the cold plasma between a plasma barrier and the biological surface.

5. The system of claim 1 , further comprising a compressible skirt configured to contain the cold plasma proximate to the biological surface.

6. The system of claim 1 , further comprising a face mask configured to contain the cold plasma proximate to the biological surface, wherein a mask intake is in fluid communication with the air conduit.

7. The system of claim 1 , further comprising a plurality of electromagnetic field generator units configured to steer or bend a discharge direction of the cold plasma between a plasma barrier and the biological surface.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2022
From: YILDIRIM, OZGUR EMEK; PLANARD-LUONG, THI HONG LIEN; JACOB, MATTHIEU; DEANE, GEOFFREY
To: L'OREAL
Reel/Frame 060172/0969 →
Continuity (10)
Provisional Application 62773944 · Nov 30, 2018
Provisional Application 62773984 · Nov 30, 2018
Provisional Application 62773958 · Nov 30, 2018
Provisional Application 62773969 · Nov 30, 2018
Provisional Application 62712860 · Jul 31, 2018
Provisional Application 62712876 · Jul 31, 2018
Provisional Application 62712849 · Jul 31, 2018
Provisional Application 62712873 · Jul 31, 2018
Provisional Application 62712812 · Jul 31, 2018
Related Publication 20200038530A1 · Feb 6, 2020
Cited By (4)
US 1,120,361 US 1,144,197 US 12,691,005 US 12,714,877